Technology News and Research

RSS

World Stem Cell Report to be published in Regenerative Medicine

The Genetics Policy Institute (GPI) and Future Medicine have announced that its 2011/12 World Stem Cell Report will be published as a special supplement to the award- winning, peer-reviewed journal Regenerative Medicine. It was also announced that Regenerative Medicine becomes the platinum media sponsor of the GPI’s 2011 World Stem Cell Summit that will take place in Pasadena, California, October 3-5.

31 Mar 2011

Clontech launches new SMARTer Ultra Low RNA Kit

Clontech Laboratories, Inc., a wholly-owned subsidiary of Takara Bio Inc., today announced the launch of its SMARTer Ultra Low RNA Kit for Illumina Sequencing, which was developed in collaboration with Illumina, Inc.

31 Mar 2011

RXi Pharmaceuticals to acquire Apthera

RXi Pharmaceuticals Corporation, a recognized leader in RNAi-based therapeutic discovery and development, and Apthera, Inc., a private biotechnology company developing a pipeline of peptide-based immunotherapies for the adjuvant treatment of HER2-positive breast and other cancers, announced today the signing of a definitive merger agreement under which RXi will acquire Apthera.

31 Mar 2011

Pacira reports net loss of $7.0 million for quarter ended December 31, 2010

Pacira Pharmaceuticals, Inc., an emerging specialty pharmaceutical company, today announced financial results for the fourth quarter and full-year ended December 31, 2010, provided an update on the execution of its pre-commercial and launch strategies for EXPAREL and established 2011 financial guidance.

31 Mar 2011

McKesson releases Horizon Cardiology 12.2 cardiovascular information system

With its new 12.2 software release, McKesson's Horizon Cardiology™ is the industry's only cardiovascular information system (CVIS) system that offers a single database, including hemodynamics, and presents the entire patient history from fetal to adulthood.

31 Mar 2011

Cancer Commons researchers publish MDMM paper in PLoS ONE journal

Cancer Commons, an initiative of CollabRx, a provider of information technology to personalize cancer treatments and accelerate research, announces the publication of a molecular disease model of melanoma which classifies the disease into molecular subtypes, rather than traditional histological or cellular subtypes, and describes treatment guidelines for each subtype, including specific assays, drugs, and clinical trials.

31 Mar 2011

Towards accurate simulation of whole working cells

Researchers have built a computer model of the crowded interior of a bacterial cell that - in a test of its response to sugar in its environment - accurately simulates the behavior of living cells.

31 Mar 2011

Surgeon presents LASIK procedure comparative study results at ASCRS Symposium

LasikPlus surgeon Dr. Lewis Groden presented results from a first-of-its-kind, comparative study at the American Society of Cataract and Refractive Surgery Symposium revealing that LASIK procedures performed with modern excimer laser technology produce excellent results and very high patient satisfaction rates.

31 Mar 2011

Scientia Vascular's PLATO microcatheters granted CE mark

Scientia Vascular, developer of innovative products that are optimized for endovascular access and therapies, announced today that its PLATOTM Microcath has received CE Mark approval, facilitating availability for European neuro, cardio and peripheral endovascular applications.

31 Mar 2011

Molecular Templates ETB preclinical data against cancer to be presented at AACR meeting

Molecular Templates, Inc., a biopharmaceutical company focused on the discovery and development of a new class of small biologic therapies called Engineered Toxin Bodies, announced today that it will present preclinical data in two poster presentations at the 102nd American Association for Cancer Research annual meeting in Orlando, FL during April 2-6, 2011.

31 Mar 2011

Cellectis 2010 total operating revenues increase 55% to EUR 15.8M

Cellectis, the genome engineering specialist, has announced its consolidated financial results for the financial year ended December 31, 2010.

31 Mar 2011

Top-line results from Biomoda's CyPath pilot study against lung cancer

Cancer diagnostics company Biomoda, Inc. today announced top-line results of its pilot study for lung cancer which shows highly significant evidence of CyPath's ability to discriminate between cancer and non-cancer groups based on sputum samples collected in a non-invasive manner.

31 Mar 2011

Coro Health earns ALFA recognition for senior care programs

Coro Health, LLC, a provider of technology-based wellness therapies designed to improve the quality of life for seniors and caregivers, today announced it has been recognized as Program to Watch by the Assisted Living Federation of America 2011 Best of the Best Awards program.

31 Mar 2011

CardioNexus to launch Panasonic CardioHealth Station at American College of Cardiology 2011 Annual Scientific Sessions

CardioNexus Corporation an affiliated company of Panasonic Healthcare Co. Ltd., will introduce Panasonic CardioHealth® Station at the 2011 Annual Scientific Sessions of the American College of Cardiology.

From PHC Europe B.V. 31 Mar 2011

Immunotec, NSU to conduct new research study in children with autism

Nova Southeastern University and the dietary supplement company Immunotec announced today that they will conduct a new research study to determine the effects of a supplement to improve behaviors in children with Autism Spectrum Disorder.

31 Mar 2011

Electrophysiologists use new robotic system to treat cardiac arrhythmias

Cardiac experts who fix arrhythmias, which are electrical problems of the heart, must perform complex catheter procedures while the heart is still beating in order to pinpoint where an electrical malfunction is taking place.

31 Mar 2011

Higher protein diets associated with greater feelings of fullness during weight loss

Dieters trying to stick to their diets may want to look no further than lean protein, according to two studies published in the prestigious journal Obesity. Including protein such as lean pork in three daily meals could reduce late-night desires to eat, increase feelings of fullness and decrease distracting thoughts about food, according to the research.

31 Mar 2011

State roundup: Md. Blue Cross probed; Mass. nonprofit hospitals may be sold

CareFirst BlueCross BlueShield, Maryland's largest insurer, confirmed to The Wall Street Journal that it received a civil investigative demand from the Justice Department but declined to comment further.

31 Mar 2011

Regular CT scans can cause secondary malignancies in older men with testicular cancer

UC Davis cancer researchers have found that older men with early-stage testicular cancer who opt for surveillance with regular CT scans over lymph node removal are at greater risk for secondary cancers.

31 Mar 2011

Regulus obtains exclusive rights from NYU for miR-33a, 33b to treat metabolic diseases

Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative new medicines targeting microRNAs, today announced that it has obtained exclusive rights from New York University for intellectual property covering methods of use in modulating microRNA-33a and microRNA-33b for metabolic diseases such as atherosclerosis and metabolic syndrome.

31 Mar 2011